These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38866245)

  • 1. A coordinative modular assembly-constructed self-reinforced nano-therapeutic agent for effective antitumor-immune activation.
    Zheng Y; Bu F; Xu C; Wu T; Zhou J; Shen W; Yin T
    J Control Release; 2024 Jul; 371():588-602. PubMed ID: 38866245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment-responsive macrophage-mediated immunotherapeutic drug delivery.
    Zhang X; Yue L; Cao L; Liu K; Yang S; Liang S; Liu L; Zhao C; Wu D; Wang Z; Tian R; Rao L
    Acta Biomater; 2024 Sep; 186():369-382. PubMed ID: 39097127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CaO
    Chen F; Yang B; Xu L; Yang J; Li J
    ChemMedChem; 2021 Jul; 16(14):2278-2286. PubMed ID: 33792182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy.
    Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ
    ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic immunotherapy with a calcium-based nanoinducer: evoking pyroptosis and remodeling tumor-associated macrophages for enhanced antitumor immune response.
    Cheng F; He L; Wang J; Lai L; Ma L; Qu K; Yang Z; Wang X; Zhao R; Weng L; Wang L
    Nanoscale; 2024 Oct; 16(39):18570-18583. PubMed ID: 39291343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 7. Supermolecular nanovehicles co-delivering TLR7/8-agonist and anti-CD47 siRNA for enhanced tumor immunotherapy.
    Shang T; Yu X; Gu Y; Du R; Cai Y; Li Y; Zheng G; Wang C; Zhang J; Liu J; Han S; Yang B
    Int J Biol Macromol; 2023 Nov; 251():126539. PubMed ID: 37634787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy.
    Gong Y; Gao W; Zhang J; Dong X; Zhu D; Ma G
    J Nanobiotechnology; 2024 Jun; 22(1):341. PubMed ID: 38890636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Delivery Nanobooster to Enhance Immunogenic Cell Death for Cancer Chemoimmunotherapy.
    Yan C; Zhao Y; Liu X; Jiang Y; Li Q; Yang L; Li X; Luo K
    ACS Appl Mater Interfaces; 2024 Jul; 16(26):33169-33181. PubMed ID: 38915234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy.
    Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J
    J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment-Specific Driven Nanoagents for Synergistic Mitochondria Damage-Related Immunogenic Cell Death and Alleviated Immunosuppression.
    Qian Y; Chen W; Wang M; Xie Y; Qiao L; Sun Q; Gao M; Li C
    Small Methods; 2024 Jul; 8(7):e2301231. PubMed ID: 38126694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ formed reactive oxygen species-responsive dipyridamole prodrug hydrogel: Spatiotemporal drug delivery for chemoimmunotherapy.
    Xiao B; Shi X; Xu X; Liu J; Pan Y; Xu H; Sun W; Slater NKH; Patra HK; Gao J; Shen Y; Tang J
    J Control Release; 2024 Nov; 375():454-466. PubMed ID: 39216598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 15. Albumin-based co-loaded sonosensitizer and STING agonist nanodelivery system for enhanced sonodynamic and immune combination antitumor therapy.
    Huang H; Du L; Su R; Li Z; Shao Y; Yuan Y; Wang C; Lu C; He Y; He H; Zhang C
    J Control Release; 2024 Nov; 375():524-536. PubMed ID: 39278356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming Tumor-Associated Macrophages with a Se-Based Core-Satellite Nanoassembly to Enhance Cancer Immunotherapy.
    Zhang X; Li G; Yin J; Pan W; Li Y; Li N; Tang B
    Nano Lett; 2024 Jul; 24(29):9104-9114. PubMed ID: 39007505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of ATP-Adenosine Axis by Engineered Biohybrid for Amplifying Immunogenic Cell Death-Mediated Antitumor Immunotherapy.
    Deng XC; Liang JL; Zhang SM; Wang YZ; Lin YT; Meng R; Wang JW; Feng J; Chen WH; Zhang XZ
    Adv Mater; 2024 Sep; 36(36):e2405673. PubMed ID: 39022876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BSA-AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma.
    Liu Z; Zhang J; Liu H; Shen H; Meng N; Qi X; Ding K; Song J; Fu R; Ding D; Feng G
    Adv Mater; 2023 Feb; 35(7):e2208692. PubMed ID: 36529696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic reinforcement of immunogenic cell death and transformation of tumor-associated macrophages via an M1-type macrophage membrane-camouflaged ferrous-supply-regeneration nanoplatform.
    Wang Y; Xu H; Wang D; Lu Y; Zhang Y; Cheng J; Xu X; Chen X; Li J
    Acta Biomater; 2024 Jan; 174():358-371. PubMed ID: 38092253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.